Neuland Laboratories Limited is a globally recognized pharmaceutical company specializing in the development and manufacture of active pharmaceutical ingredients (APIs), custom manufacturing, and contract development services for innovator and generic pharmaceutical companies. Founded in 1984, the company has established itself as a trusted partner for complex chemistry and process development, serving customers across more than 80 countries. Neuland possesses strong expertise in manufacturing high-value APIs for therapeutic areas including cardiovascular, central nervous system, oncology, respiratory, and anti-infective medicines. Its integrated capabilities span process research, scale-up, commercial manufacturing, and custom synthesis, enabling pharmaceutical innovators to accelerate product development. The company operates advanced manufacturing facilities approved by leading global regulatory agencies, including the US FDA, EMA, PMDA, and other international authorities. Through continuous investment in research, process innovation, and sustainability, Neuland strengthens its position as a preferred global API and CDMO partner while delivering high-quality pharmaceutical ingredients to healthcare companies worldwide.
NSE: NEULANDLAB | BSE: 524558
Hyderabad, Telangana, India
~3,000 employees
